Author: Yan, Xiujuan; Li, Yingxiu; Choi, Yun Ho; Wang, Chongyang; Piao, Yihua; Ye, Jing; Jiang, Jingzhi; Li, Liangchang; Xu, Huixian; Cui, Qingsong; Yan, Guanghai; Jin, Minggen
Title: Protective Effect and Mechanism of Alprostadil in Acute Respiratory Distress Syndrome Induced by Oleic Acid in Rats Document date: 2018_10_8
ID: 7ea7ur3b_29
Snippet: Western blot analysis showed that phosphorylation of MAPKs was significantly up-regulated by OA, including p-p38 MAPK ( Figure 5A , 5B), p-ERK1/2 ( Figure 5A , 5C), and p-JNK ( Figure 5A, 5D) . Moreover, OA administration markedly increased the phosphorylation of p65 ( Figure 5A, 5E) conditions. It has been confirmed that serum ACE activity is significantly elevated in active ARDS patients, and that the measurement of serum ACE activity is useful.....
Document: Western blot analysis showed that phosphorylation of MAPKs was significantly up-regulated by OA, including p-p38 MAPK ( Figure 5A , 5B), p-ERK1/2 ( Figure 5A , 5C), and p-JNK ( Figure 5A, 5D) . Moreover, OA administration markedly increased the phosphorylation of p65 ( Figure 5A, 5E) conditions. It has been confirmed that serum ACE activity is significantly elevated in active ARDS patients, and that the measurement of serum ACE activity is useful in following the clinical course of the disease [39] . Several studies have suggested that monitoring serum ACE is useful as an indicator of endothelial cell integrity [40] . Staining results showed that the expression of ACE protein in the lung tissue from the OA model group was obviously higher than that from the control group ( Figure 7A ), suggesting that ACE is involved in the development of ARDS. In contrast, in the OA + Alprostadil (5 and 10 μg/kg) group, the expression of ACE was partially reduced compared with that in the OA model group (Figure 7A, 7B) .
Search related documents:
Co phrase search for related documents- ACE activity and control group: 1, 2, 3, 4, 5, 6
- ACE expression and cell integrity: 1
- ACE expression and clinical course: 1, 2, 3, 4
- ACE expression and control group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- ACE protein and cell integrity: 1
- ACE protein and clinical course: 1, 2
- ACE protein and control group: 1, 2, 3
- ACE protein expression and cell integrity: 1
- ACE protein expression and control group: 1, 2, 3
- active ARDS patient and ARDS patient: 1
- ARDS development and clinical course: 1, 2, 3, 4, 5, 6
- ARDS development and control group: 1, 2, 3, 4
- ARDS development and disease clinical course: 1
- ARDS patient and clinical course: 1, 2, 3, 4, 5, 6
- ARDS patient and control group: 1, 2, 3, 4, 5
- cell integrity and control group: 1, 2, 3
- clinical course and control group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56
- clinical course and disease clinical course: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- control group and disease clinical course: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
Co phrase search for related documents, hyperlinks ordered by date